Development and Efficacy of an ADHD-CBT Program of Individual Cognitive Behavioral Therapy for Attention Deficit/Hyperactivity Disorder in Adulthood

JRCT ID: jRCT1030220650

Registered date:22/02/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Attention Deficit / Hyperactivity Disorder
• Date of first enrollment: 22/02/2023
• Target sample size: 12
• Study type: Interventional
• Intervention(s): This ADHD-CBT program was developed based on Safren's manual on individual cognitive-behavioral therapy for ADHD in adulthood. It involves 12-16 in-person weekly sessions, consisting of an interview and a task for the examinee to complete outside the interview. However, due to the developmental characteristics of adult ADHD, noncompliance is assumed with assigned tasks. Therefore, rather than focusing on compliance with homework assignments, this program emphasizes building a relationship between the therapist and patient that facilitates continued participation.

Outcome(s)

• Primary Outcome: Conners' Adult ADHD Rating Scales Japanese Version

Secondary Outcome

QIDS-J
EQ-5D
SCID
CGI-S
AQ

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: <= 65age old
• Gender: Both

Include criteria

1. Currently meeting the diagnostic criteria for ADHD and being treated
2. Clinical severity of ADHD symptoms (as assessed by CAARS or CGI-S)
3. 20 to 65 years of age
4. History of being treated and followed for at least three months, completed medication adjustments, and are on stable doses during the study period
5. Willing to return for required follow-up visits throughout the study period

Exclude criteria

1. The patient has been hospitalized within 30 days prior to the date of registration
2. The patient currently presents with psychotic disorders, substance use disorders, manic episodes, or neurocognitive disorders (as confirmed by SCID)
3. The patient possesses severe suicidal ideation
4. The patient is identified as having an intelligence quotient of 80 (as assessed by WAIS-IV)
5. The patient has other issues that interfere with the implementation of cognitive behavioral therapy
6. The patient has been or is currently under structured treatment

Related Information

• Primary Sponsor: Kuga Hironori
• Source(s) of Monetary Support: AMED